Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
Merck
Medtronic
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Clindamycin palmitate hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for clindamycin palmitate hydrochloride and what is the scope of patent protection?

Clindamycin palmitate hydrochloride is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Amneal Pharms, Aurobindo Pharma Ltd, Heritage Pharms Inc, Lyne, Mylan, Orit Labs Llc, and Paddock Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-five drug master file entries for clindamycin palmitate hydrochloride. Ten suppliers are listed for this compound.

Summary for clindamycin palmitate hydrochloride
Pharmacology for clindamycin palmitate hydrochloride
Synonyms for clindamycin palmitate hydrochloride
(2R,3R,4S,5R,6R)-6-((1R,2R)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl palmitate hydrochloride
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride
[(2R,4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate hydrochloride
[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate hydrochloride
25507-04-4
34850-73-2
35208-55-0 (Parent)
36688-78-5
6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)formamido]propyl}-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl hexadecanoate hydrochloride
AB2000687
AB51459
AC-8823
AC1L1OVK
AKOS015963324
AKOS030242182
AN-7626
BCP28438
C-23416
C34H63ClN2O6S.HCl
C34H64Cl2N2O6S
CAS-25507-04-4
CHEBI:34647
CHEMBL1200632
Cleocin Pediatric
Cleocin pediatric (TN)
Clindamycin 2-palmitate hydrochloride
Clindamycin palmitate
Clindamycin palmitate HCl
Clindamycin palmitate hydrochloride (JAN/USP)
Clindamycin Palmitate Hydrochloride [USAN:JAN]
Clindamycin palmitate hydrochloride [USAN:USP:JAN]
Clindamycin-2-palmitate, monohydrochloride
CTK8F8720
D01990
DSSTox_CID_28660
DSSTox_GSID_48734
DSSTox_RID_82930
DTXSID3048734
GF24500000
J-016026
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-
LS-174102
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride
MolPort-003-983-293
MolPort-028-599-793
NCGC00185773-02
NIOSH/GF2450000
NSC-759141
NSC759141
O721
Pharmakon1600-01505470
s2596
SCHEMBL41416
SW219516-1
Tox21_113175
U 25179E
U-25,179 E
U-25179-E
UNII-VN9A8JM7M7
VN9A8JM7M7

US Patents and Regulatory Information for clindamycin palmitate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lyne CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 201821-001 Aug 28, 2012 AA RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 202409-001 Apr 30, 2013 AA RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 062644-001 Apr 7, 1986 AA RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Mallinckrodt
Moodys
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.